Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial

The appropriate age range for breast cancer screening remains a matter of debate. We aimed to estimate the effect of mammographic screening at ages 40–48 years on breast cancer mortality. We did a randomised, controlled trial involving 23 breast screening units across Great Britain. We randomly assi...

Ausführliche Beschreibung